NCT07827417 Comparative Effects of Reactive Balance Training and Task-Oriented Training on Postural Stability in Patients With Diabetic Peripheral Neuropathy
| NCT ID | NCT07827417 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Diabetic Neuropathies |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2026-02-11 |
| Primary Completion | 2027-01-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2026-02-11 with a primary completion date of 2027-01-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Diabetic peripheral neuropathy (DPN) is a common complication of prolonged hyperglycemia that damages peripheral nerves, leading to impaired sensory function, increased fall risk, and reduced quality of life. Balance training has shown promising effects in improving postural stability and reducing fall risk in individuals with DPN by engaging visual, vestibular, and proprioceptive systems and promoting central nervous system adaptation. This randomized controlled trial aims to compare the effects of Reactive Balance Training (RBT) and Task-Oriented Training (TOT) on postural stability in patients with DPN. The study will be a single-blinded, two-group randomized controlled trial conducted over one year at Foundation University College of Physical Therapy. A sample of 36 participants will be recruited through convenience sampling and randomly allocated into two groups using the coin-toss method. Ethical approval will be obtained from the FUSH ERC, and written informed consent will be obtained after explaining the study procedures, risks, and benefits. Postural stability will be assessed using the Posture Assessment Checklist, Mini-BESTest, Functional Reach Test (FRT), and Timed Up and Go (TUG). Group A will receive RBT, while Group B will receive TOT. Each session will last 30-40 minutes, including a 5-7-minute warm-up, 20-30 minutes of group-specific intervention, and a 5-minute cool-down. Participants will receive 60-second rest intervals after every three sets or 8-10 repetitions. The intervention will continue for six weeks, with three sessions per week, totaling 18 sessions. Assessments will be conducted at baseline, at week 3, and post-intervention at week 6 using the same outcome measures.
Eligibility Criteria
Inclusion Criteria: * Both gender * Adults aged 40 years and above diagnosed with type 2 diabetes mellitus. * Diagnosed cases diabetic peripheral neuropathy. * Able to stand and walk independently * Balance or postural stability, as indicated by clinical tests (e.g., mini-bestest score below -normative values/21 or less or history of falls/near-falls). * Functional reach test with scores 6-10 inches * Time up and go up to 14 seconds Exclusion Criteria: * History of neurological disorders other than DPN (e.g., stroke, Parkinson's disease, multiple sclerosis). * Musculoskeletal disorders affecting lower limb function (e.g., grade 4 osteoarthritis, recent fractures). * Uncontrolled cardiovascular conditions (e.g., unstable angina, recent myocardial infarction). * Vestibular impairments affecting balance independently of DPN. * Diabetic complications that contraindicate exercise (e.g., active foot ulcers, severe retinopathy).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07827417 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Diabetic Neuropathies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07827417 currently recruiting?
Yes, NCT07827417 is actively recruiting participants. Contact the research team at hifzasafdar482@gmail.com for enrollment information.
Where is the NCT07827417 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07827417 clinical trial?
NCT07827417 is sponsored by Foundation University Islamabad. The trial plans to enroll 36 participants.